Canada markets closed

Akero Therapeutics, Inc. (0K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
17.59-1.15 (-6.13%)
At close: 08:04AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.27B
Enterprise Value 780.53M
Trailing P/E 8.45
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.43
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.25

Trading Information

Stock Price History

Beta (5Y Monthly) -0.38
52-Week Change 3-55.57%
S&P500 52-Week Change 322.36%
52 Week High 355.00
52 Week Low 310.80
50-Day Moving Average 322.64
200-Day Moving Average 326.19

Share Statistics

Avg Vol (3 month) 318
Avg Vol (10 day) 35
Shares Outstanding 568.95M
Implied Shares Outstanding 672.11M
Float 846.07M
% Held by Insiders 15.77%
% Held by Institutions 193.35%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.07%
Return on Equity (ttm)-35.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -172.84M
Net Income Avi to Common (ttm)-151.76M
Diluted EPS (ttm)-2.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)550.01M
Total Cash Per Share (mrq)9.77
Total Debt (mrq)26.04M
Total Debt/Equity (mrq)4.86%
Current Ratio (mrq)29.27
Book Value Per Share (mrq)9.60

Cash Flow Statement

Operating Cash Flow (ttm)-145.37M
Levered Free Cash Flow (ttm)-93.79M